NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces Dipeptidyl Peptidase IV Assay Kit - Dipeptidyl Peptidase IV (DPPIV) assay kit provides a convenient assay for enzyme inhibitors and activators screening or for the continuous assay of enzyme activity - AnaSpec.com
AnaSpec Introduces Dipeptidyl Peptidase IV Assay Kit

 

NewswireTODAY - /newswire/ - Fremont, CA, United States, 2011/06/21 - Dipeptidyl Peptidase IV (DPPIV) assay kit provides a convenient assay for enzyme inhibitors and activators screening or for the continuous assay of enzyme activity - AnaSpec.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AnaSpec, EGT Group is pleased to introduce a new long wavelength fluorimetric assay kit for determining Dipeptidyl Peptidase IV (DPPIV) activity, the SensoLyte® Rh110 DPPIV Assay Kit. This kit contains a substrate that emits in the green range of 520 nm when cleaved by DPPIV. The kit provides a convenient assay for enzyme inhibitors and activators screening or for the continuous assay of enzyme activity. Cleavage of the fluorogenic substrate by DPPIV generates the Rh110 (rhodamine 110) fluorophore which has a bright green fluorescence. Fluorescence can be monitored at excitation/emission=490/520 nm. The longer wavelength spectra and higher extinction coefficient of Rh110 provide greater sensitivity and less interference from other reaction components.

Dipeptidyl Peptidase IV (DPPIV, DPP-4, CD26) is a cell surface serine protease, which cleaves Xaa-Pro or less efficiently Xaa-Ala dipeptides from the N-terminus.1-3 DPPIV possesses an identical function to the T-cell surface antigen (CD26).1 DPPIV is commonly found in mammalian tissues and is highly expressed in hepatocytes, pancreatic epithelial cells, intestinal epithelium, and kidney cortex.3 DPPIV plays an important role in glucose homeostasis by proteolysis of incretins such as glucagon-like peptide-1 (GLP-1). Due to its role in degradation of GLP-1, DPPIV is a therapeutic target for type 2 diabetes.

The SensoLyte®AMC DPPIV Assay Kit, which employs an AMC fluorogenic substrate, is also available from AnaSpec. This kit is optimized for screening of enzyme inhibitors. This kit contains an AMC labeled substrate that has a high reactivity and low background. Upon protease cleavage, this substrate generates the AMC fluorophore emitting bright blue fluorescence that can be monitored at excitation/emission=354/442 nm. Increase in AMC fluorescence is proportional to DPPIV activity.

References
1. Zhu, L. et al, J. Biol. Chem. 278, 22418 (2003).
2. Mentlein, R. Regulatory Peptides 85, 9 (1998).
3. Qi, SY. et al, Biochem. J. 373, 179 (2003).

AnaSpec, EGT Group

AnaSpec, EGT Group (anaspec.com) is a leading provider of integrated proteomics and genomics solutions™ for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces Dipeptidyl Peptidase IV Assay Kit

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Tiffany Kao - AnaSpec.com 
510-791-9560
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

SCHOTT Pharma Unveils Innovative Nest Design for Ready-to-use Cartridges
Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-class MAIT Cell Engager in Immuno-oncology
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry through Consistent Quality Assurance, On-time Delivery
Bylvay® (odevixibat) Data Shows Sustained Improvement in Severe Itch and Serum Bile Acid Levels in Patients with PFIC and ALGS
Genome BC, STEMCELL Technologies and UBC Partner to Accelerate the Ability to Develop Stem Cells
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with its Microarray Detection Platform
BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients
Ipsen’s Kayfanda® (odevixibat) Approved in European Union for Cholestatic Pruritus in Alagille Syndrome, A Rare Liver Disease
STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value
BASF Declares Force Majeure for Selected Vitamin A, Vitamin E, and Carotenoid Products As Well As Selected Aroma Ingredients
Ono Pharmaceutical Co., Ltd Enters into A New Option and Research Collaboration Agreement with Monash University
Aragen Life Sciences Ltd Receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery
Ipsen’s Iqirvo® Receives U.S. FDA Accelerated Approval as A First-in-class PPAR Treatment for Primary Biliary Cholangitis
Ipsen Presents Long-term Elafibranor Efficacy and Itch-related Quality of Life Data in Patients with Primary Biliary Cholangitis

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Limelon Advertising, Co.





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)